Kefton-2

TargetMol
Product Code: TAR-T32373
Supplier: TargetMol
CodeSizePrice
TAR-T32373-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Kefton-2 is bioactive chemical.
CAS:
6041-00-5
Formula:
C31H40O2
Molecular Weight:
444.659
Purity:
0.98
SMILES:
CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=C(C)C(=O)c2ccccc2C1=O

References

1. Iwamoto J. Vitamin K? therapy for postmenopausal osteoporosis. Nutrients. 2014 May 16;6(5):1971-80. doi: 10.3390/nu6051971. Review. PubMed PMID: 24841104; PubMed Central PMCID: PMC4042573. 2. Inoue T, Dohara Y, Sugihara K, Fujisaki S, Nagatani Y. [Intravenous Kefton-2, a hemostatic, in oral surgery]. Shikai Tenbo. 1980 Nov;56(5):871-5. Japanese. PubMed PMID: 6942517. 3. Shearer MJ, Newman P. Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res. 2014 Mar;55(3):345-62. doi: 10.1194/jlr.R045559. Epub 2014 Jan 31. Review. PubMed PMID: 24489112; PubMed Central PMCID: PMC3934721. 4. Jiang Y, Zhang ZL, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial. Clin Interv Aging. 2014;9:121-7. doi: 10.2147/CIA.S54107. Epub 2014 Jan 8. PubMed PMID: 24426779; PubMed Central PMCID: PMC3890406.